Comparison the effect of intravenous magnesium sulfate and intravenous ketorolac on pain of patients with renal colic affiliated to acute emergency department of Ahvaz Golestan hospital

Comparison the effect of intravenous magnesium sulfate and intravenous ketorolac on pain of patients with renal colic

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016050125027N2

Enrollment

Registered

2016-12-21

Start date

2016-12-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic. Unspecified renal colic

Interventions

Intervention 1: Patients in first group will receive ketorolac via intravenous with dosage of 30 mg in combination to 100 cc intravenous normal saline during 15 minutes. Intervention 2: Patients in se

Treatment - Drugs

Patients in first group will receive ketorolac via intravenous with dosage of 30 mg in combination to 100 cc intravenous normal saline during 15 minutes

Patients in second group will receive 50 mg per kilogram intravenous magnesium sulfate 50% with total dosage of 100 cc during 15 minutes.

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: diagnosis of renal colic with sonography; age of 18-55 years; having pain score of 5 based on visual analog score in admission time. Exclusion criteria: history of heart, liver, kidney, metabolic diseases and seizures; systolic blood pressure below 90 mmHg; fever more than 37 degrees Celsius; pregnancy; abdominal pain and probable peritonitis; using calcium channel blockers.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain severity. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Visual analog scale.	—

Secondary

Measure	Time frame
Pulse rate. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Blood pressure rate. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Atrial oxygen saturation. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Respiratory rate. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Nausea and vomiting. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.	—

Measure

Time frame

Pulse rate. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Blood pressure rate. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Atrial oxygen saturation. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Respiratory rate. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.;Nausea and vomiting. Timepoint: In 15, 30, 45 and 60 minutes after intervention. Method of measurement: Researcher-made questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Maleki Varaki

Ahvaz Jundishapur University of Medical Sciences

Maleki-m@ajums.ac.iradelaryan61@gmail.com+98 61 3320 8342

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026